Hazard ratio for recurrent relapses - A modern efficacy measure for clinical trials in relapsing multiple sclerosis

被引：0
|
作者：
Bogumil, T
Jakobs, P
Salazar-Grueso, E
Fleming, T
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A324 / A324
页数：1
相关论文
共 50 条
  • [21] Summary measure statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis
    Liu, C
    Po, ALW
    Blumhardt, LD
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (06): : 726 - 729
  • [22] The hazard ratio as a measure of effect in clinical trials of elderly populations: common pitfalls and misconceptions
    Stefanos Roumeliotis
    Graziella D’Arrigo
    Giovanni Tripepi
    Aging Clinical and Experimental Research, 2021, 33 : 505 - 511
  • [23] The hazard ratio as a measure of effect in clinical trials of elderly populations: common pitfalls and misconceptions
    Roumeliotis, Stefanos
    D'Arrigo, Graziella
    Tripepi, Giovanni
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (03) : 505 - 511
  • [24] The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials
    Bermel, Robert A.
    Fisher, Elizabeth
    Cohen, Jeffrey A.
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (04) : 687 - 701
  • [25] Clinical efficacy of fingolimod and identification of predictors of relapses in an Italian cohort of multiple sclerosis patients
    Esposito, F.
    Ferre, L.
    Radaelli, M.
    Clarelli, F.
    Sferruzza, G.
    Sangalli, F.
    Rodegher, M.
    Messina, M. J.
    Moiola, L.
    Colombo, B.
    Rocca, M. A.
    Filippi, M.
    Boneschi, F. G. Martinelli
    Comi, G.
    Martinelli, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 538 - 539
  • [26] The dynamics of relapses during treatment switch in relapsing-remitting multiple sclerosis
    Frascoli, Federico
    Roos, Izanne
    Malpas, Charles B.
    Kalincik, Tomas
    JOURNAL OF THEORETICAL BIOLOGY, 2022, 541
  • [27] Relationship between relapses and quality of life in patients with relapsing remitting multiple sclerosis
    Grau-Lopez, L.
    Tintore, M.
    Ramio-Torrenta, L.
    Brieva, L.
    Saiz, A.
    Nos, C.
    Cano, A.
    Carmona, O.
    Hervas, J. V.
    Montalban, X.
    Ramo-Tello, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 420 - 420
  • [28] Effects of natalizumab on relapses and MRI outcomes in Hispanic patients with relapsing multiple sclerosis
    Herbert, J.
    Rivera, V.
    Ford, C.
    Pace, A.
    Hyde, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S232 - S232
  • [29] Association of MRI metrics and clinical relapses to explain long-term disability changes in relapsing multiple sclerosis
    Giorgio, A.
    Sormani, M. P.
    Stromillo, M. L.
    Bartolozzi, M. L.
    Rossi, F.
    Battaglini, M.
    De Leucio, A.
    Guidi, L.
    Maritato, P.
    Portaccio, E.
    Amato, M. P.
    Federico, A.
    De Stefano, N.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 510 - 511
  • [30] Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis
    Cree, Bruce A. C.
    Cohen, Jeffrey A.
    Reder, Anthony T.
    Tomic, Davorka
    Silva, Diego
    Piani Meier, Daniela
    Laflamme, Annik K.
    Ritter, Shannon
    Leppert, David
    Kappos, Ludwig
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) : 2219 - 2231
12345